OTTAWA, Ontario (AP) – Plans to distribute the first 300,000 doses of the Johnson & Johnson (J&J) COVID-19 vaccine in Canada next week are on hold after Health Canada learned part of them were manufactured at a Maryland facility that messed up the ingredients in 15 million doses bound for the U.S. market.
The Emergent Biosolutions facility in Baltimore was recently cited by the U.S. Food and Drug Administration for violations including cleaning and sterilization failures, the potential for cross-contamination and failure to follow required protocols.
The FDA ordered the facility to stop making more J&J vaccine until the problems are corrected and the earlier mistake on the doses resulted in all 15 million being destroyed.
The Biden administration has ended the pause and will allow Johnson & Johnson to resume Chinese coronavirus vaccinations. https://t.co/BYaRTDmnC6
— Breitbart News (@BreitbartNews) April 25, 2021
Health Canada had already